L2 Childhood Acute Lymphoblastic Leukemia
4 clinical trials · Condition
◉ Watch L2 Childhood Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission (NCT00382109) | Children's Oncology Group | 2007-03-01 |
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT00381680) | Children's Oncology Group | 2007-03-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945) | National Cancer Institute (NCI) | 2003-06-01 |
| Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia (NCT00049569) | National Cancer Institute (NCI) | 2003-01-01 |
Track L2 Childhood Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.